My WebLink
|
Help
|
About
|
Sign Out
Home
COM 0140.006 2002-2004
ClerkCouncil
>
Council Records
>
Communications
>
2002-2004
>
COM 0140.006 2002-2004
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
5/12/2008 9:32:38 PM
Creation date
5/10/2008 12:15:36 AM
Metadata
Fields
Template:
Communications
Communications - Type
COM
Communications - Council Term
2002-2004
Communication
0140
Point
006
Author
Submitted by Dennis Shields, Reverend, The Religion of Jesus Church
Communications - Referred To
COUNCIL
Comments
Presented: Council - 3/19/03
Document Relationships
BIL 059 Draft 01 2002-2004
(Related)
Path:
\Council Records\Bills\2002-2004
COM 0140.000 2002-2004
(Related)
Path:
\Council Records\Communications\2002-2004
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
19
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
<br /> I,r <br /> I-he Lbogaine Dossier <br /> NYl' Conference un <br /> Lbogaine Nun ~-6. 1999 <br /> Howard S. Lo[su( <br /> Darien ibw_a Run <br /> ,Main Search Science Opinion i Literature Lulls Treatment Bou6shop ~ Feedbac6 <br /> IBOGAINEIV CHE IREATMENTOI~ <br /> CHEMICAL. DEPENDENCE DISORDERS: <br /> CLINICAL PERSPECTIVIS <br /> I:\ Preliminan Rzcizw 1 <br /> H.S_ LUTSOF <br /> I `!9J <br /> Dedicated to the ~wr6 J. Bastiuans :utd V.F.P. -adriuuro <br /> in mcmon of V. Kribus <br /> fhe pnmun purpose uY [h~, paper a lu provide general information to the chniaan who will be usm_~ <br /> the Lorsof Proceduresm Ilioutarel_ 19931 developed by VDA International. Inc. in which Ibogaine is <br /> admimis[ered to [teat chzm~cal dependence disorders. This is a preliminan repon_ Fhe patient base <br /> upon which m. conclusion, have been made totals thin}-flue treatment episodes. 411 clinical <br /> ubsenationn comducted after 1963 have been rnadz un patients treated outside of thr I ~nited Stares- <br /> Ibogaure i, not a subsutu[e lur narcumcs or ,rimulants, n nut uddictinu and a ~~nrn m a singlz <br /> administruuon modalin I S-AM 1. It b u chemical dependzncu uuerrupler. Retrraunent may <br /> uccasionalh be needed anal the person being [reated with Ibogaine is able a. zsnneuish ccnum <br /> zomditioned responses related to drugs they abusr. Earh data suggests [hat a penod ofappru~imareh <br /> nxi ~ can of intermittent treatments may be reyuired to utain the goal of lane-feint abstinence Rom <br /> narcotics and srimulanu for main patients. I~hc mujorin oCpatien[s treated with Ibogaine amain <br /> Gee Rom zhzmical dependence lur a period of three to ,n months after a single dux. ,lppro.~imareh <br /> Izn percent of patients u-eatzd wuh Ibogaine remain Rer o(ehemical dependzncz for two or more <br /> ~ ears ttom a single trciunent and an zyual percentage rcmm to drug use within n~o wee6s utter <br /> treamlent. ,Multiple administrutioro of Ibogaime over a penod of[ime are genzralh more ztlectisr in <br /> <br />
The URL can be used to link to this page
Your browser does not support the video tag.